BE2020694/Key R&D Program of Jiangsu Province [Social Development][Grants and Funding] - Search Results

Year	Number of Results
2021	5
2023	3
2024	0

1

Racial Disparities in MiT Family Translocation Renal Cell Carcinoma.

Lu X, Tawanaie Pour Sedehi N, Su X, Yan F, Alhalabi O, Tannir NM, Malouf GG. Lu X, et al. Oncologist. 2023 Nov 2;28(11):1009-1013. doi: 10.1093/oncolo/oyad173. Oncologist. 2023. PMID: 37315151 Free PMC article.

2

Integration of scRNA-seq and bulk RNA-seq constructs a stemness-related signature for predicting prognosis and immunotherapy responses in hepatocellular carcinoma.

Wang X, Chen X, Zhao M, Li G, Cai D, Yan F, Fang J. Wang X, et al. J Cancer Res Clin Oncol. 2023 Nov;149(15):13823-13839. doi: 10.1007/s00432-023-05202-2. Epub 2023 Aug 3. J Cancer Res Clin Oncol. 2023. PMID: 37535162

3

Identification of Immune Function-Related Subtypes in Cutaneous Melanoma.

Liu L, Zhu J, Jin T, Huang M, Chen Y, Xu L, Chen W, Jiang B, Yan F. Liu L, et al. Life (Basel). 2021 Sep 6;11(9):925. doi: 10.3390/life11090925. Life (Basel). 2021. PMID: 34575074 Free PMC article.

4

MOVICS: an R package for multi-omics integration and visualization in cancer subtyping.

Lu X, Meng J, Zhou Y, Jiang L, Yan F. Lu X, et al. Bioinformatics. 2021 Apr 1;36(22-23):5539-5541. doi: 10.1093/bioinformatics/btaa1018. Bioinformatics. 2021. PMID: 33315104

SUMMARY: Stratification of cancer patients into distinct molecular subgroups based on multi-omics data is an important issue in the context of precision medicine. Here, we present MOVICS, an R package for multi-omics integration and visualization in cancer subtyping. ...

SUMMARY: Stratification of cancer patients into distinct molecular subgroups based on multi-omics data is an important issue in the context …

5

Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.

Cai D, Liu T, Fang J, Liu Y. Cai D, et al. J Cancer Res Clin Oncol. 2023 Sep;149(11):9151-9165. doi: 10.1007/s00432-023-04831-x. Epub 2023 May 13. J Cancer Res Clin Oncol. 2023. PMID: 37178426

6

Tumour microenvironment-based molecular profiling reveals ideal candidates for high-grade serous ovarian cancer immunotherapy.

Lu X, Ji C, Jiang L, Zhu Y, Zhou Y, Meng J, Gao J, Lu T, Ye J, Yan F. Lu X, et al. Cell Prolif. 2021 Mar;54(3):e12979. doi: 10.1111/cpr.12979. Epub 2021 Jan 31. Cell Prolif. 2021. PMID: 33522069 Free PMC article.

7

Multi-omics consensus ensemble refines the classification of muscle-invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies.

Lu X, Meng J, Su L, Jiang L, Wang H, Zhu J, Huang M, Cheng W, Xu L, Ruan X, Yeh S, Liang C, Yan F. Lu X, et al. Clin Transl Med. 2021 Dec;11(12):e601. doi: 10.1002/ctm2.601. Clin Transl Med. 2021. PMID: 34936229 Free PMC article. No abstract available.

8

Integrated multi-omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer.

Meng J, Lu X, Jin C, Zhou Y, Ge Q, Zhou J, Hao Z, Yan F, Zhang M, Liang C. Meng J, et al. Clin Transl Med. 2021 Dec;11(12):e655. doi: 10.1002/ctm2.655. Clin Transl Med. 2021. PMID: 34936729 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year